ON - LINE HAEMODIAFILTRATION WITH AND WITHOUT ACETATE
https://doi.org/10.24884/1561-6274-2009-13-2-50-54
Abstract
BACKGROUND. In patients on on-line convective treatments, given the considerable quantity of dialysis fluid re-infused, the small amount of acetate present in bicarbonate dialysis fluid as a pH stabilizing factor may allow a significant transfer of that anion to the patient, possibly inducing cytokine activation. METHODS. To verify this hypothesis, we performed on-line haemodiafiltration (OL-HDF) with (3 mmol/l) and without acetate in dialysis fluid in a cross-over randomized order on 12 prevalent patients. RESULTS. In comparison with the pre-treatment values, plasma acetate levels were unchanged during and after acetate-free OL-HDF, while they were 5–6 times higher in the course of OL-HDF containing acetate in dialysis fluid; plasma acetate levels returned to basal values 2 h after the end of the procedure. The total increase of bases in the patient attributable to acetate was 36%. Plasma bicarbonate values at the end of treatment were significantly lower in treatments without acetate, as compared to those with acetate. Interleukin-6 plasma levels were super-imposable at the beginning and in the course of the two methods compared, but there was a tendency towards a greater increase at an interval of 2 h following OL-HDF with acetate. CONCLUSIONS. Our preliminary results confirm the assumption that body gain of acetate is particularly high in convective treatments, while acetate-free OL-HDF slows down acetate burden. Clinical advantages due to these effects should be evaluated in properly designed prospective studies.
About the Authors
F. PizzarelliItaly
Dr Francesco Pizzarelli, Head o f Nephrology Unit
Via dell’ Antella 58, 50011 Antella-Firenze, Italy
T. Cerrai
Italy
Nephrology Unit
P. Dattolo
Italy
Nephrology Unit
G. Ferro
Italy
Nephrology Unit
References
1. Agliata S, Atti M, Fortina F et al. Acetate in the dialysate in bicarbonate dialysis. Blood Purif 1992; 10: 88
2. Amore A, Cirina P, Mitola S et al. Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol 1997; 9: 1431-1436
3. Noris M, Todeschini M, Casiraghi F et al. Effect of acetate, bicarbonate dialysis and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension. Am J Kidney Dis 1998; 32: 115-124
4. Todeschini M, Macconi D, Garcia Fernandez N et al. Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. Am J Kidney Dis 2002; 40: 783-793
5. Fournier G, Potier J, Thebaud HE el al. Substitution of acetic acid for hydrochloric acid in the bicarbonate buffered dialysate. Artif Organs 1998; 22: 608-613
6. Lundquist F, Tygstrup N, Winkler K, Mellemgaard K, Munck-Petersen S. Ethanol metabolism and production of free acetate in the human liver. J Clin Invest 1962; 41: 955-961
7. Pizzarelli F, Tetta C, Cerrai T, Maggiore Q. Double-chamber on-line hemodiafiltration: a novel technique with intra-treatment monitoring of dialysate ultrafilter integrity. Blood Purif 2000; 18: 237-241
8. Pizzarelli F, Cerrai T, Tetta C. Paired hemodiafiltration: technical assessment and preliminary clinical results. In: Ronco C (ed.), Contributions to Nephrology, Vol. 138, Karger: Basel 2003; 99-105
9. Fernandez PC, Cohen RM, Feldman GM. The concept of bicarbonate distribution space: the crucial role of body buffers. Kidney Int 1989; 36: 747-752
10. Novello A, Kelsh RC, Esterling RE. Acetate intolerance during hemodialysis. Clin Nephrol 1976; 5: 29-32
11. Graefe U, Milutinovich J, Follette WC, Vizzo JE, Babb AL, Scribner BH. Less dialysis-induced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 1978; 88: 332-336
12. Veech R. The untoward effects of the anions of dialysis fluids. Kidney Int 1988; 34: 587-597
13. Bingel M, Koch KM, Lonnemann G, Dinarello CA, Shaldon S. Enhancement of in vitro human interleukin-1 production by sodium acetate. Lancet 1987; 1: 14-16
14. Anderson J, Briefel G, Jones JM, Ryu JH, McGuire M, Pyo Yun Y. Effects of acetate dialysate on transforming growth factor (3,, interleukin and Pi-mkroglobulin plasma levels. Kidney Int 1991; 40: 1110-1117
15. Campagnari F, Webster LT. Purification and properties of acetyl coenzyme A synthetase from bovine heart mitochondria. J Biol Chem 1963; 238: 1628-1633
16. Zucchelli P, Santoro A, Ferrari G, Spongano M. Acetate-free biofiltration: hemodiafiltration with base-free dialysate. Blood Purif 1990; 8: 14-22
17. Kaizu Y, Kimura M, Yonemana T et al. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998; 31: 93-100
18. Rao M, Guo D, Perianayagam MC et al. Plasma Interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2005; 45: 324-333
19. Panichi V, Migliori M, De Pietro S el al. The link of biocompatibility to cytokine production. Kidney Int 2000; 58: S96-S103
20. Kushner I, Broder ML, Karp D. Control of the acute phase response: serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978; 61: 235-242
21. Caglar K, Peng Y, Pupim LB et al. Inflammatory signals associated with hemodialysis. Kidney Int 2002; 62: 1408-1416
Review
For citations:
Pizzarelli F., Cerrai T., Dattolo P., Ferro G. ON - LINE HAEMODIAFILTRATION WITH AND WITHOUT ACETATE. Nephrology (Saint-Petersburg). 2009;13(2):50-54. (In Russ.) https://doi.org/10.24884/1561-6274-2009-13-2-50-54